Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angiotensin II Receptor Inhibition to Improve Microvascular Function in Women Who Have Had Preeclampsia

NCT04632589 is registered in ClinicalTrials.gov with Anna Stanhewicz, PhD as lead sponsor.

NCT NCT04632589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04632589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angiotensin II Receptor Inhibition to Improve Microvascular Function in Women Who Have Had Preeclampsia
Lead sponsor
Anna Stanhewicz, PhD
Phase
Phase 1
Overall status
Completed
Start date
November 22, 2020
Completion date
March 13, 2025
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia postpartum